SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-057990
Filing Date
2018-11-07
Accepted
2018-11-07 16:31:39
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv505296_10q.htm 10-Q 325707
2 EXHIBIT 10.1 tv505296_ex10-1.htm EX-10.1 580237
3 EXHIBIT 31.1 tv505296_ex31-1.htm EX-31.1 10746
4 EXHIBIT 31.2 tv505296_ex31-2.htm EX-31.2 9732
5 EXHIBIT 32.1 tv505296_ex32-1.htm EX-32.1 4337
6 EXHIBIT 32.2 tv505296_ex32-2.htm EX-32.2 4419
  Complete submission text file 0001144204-18-057990.txt   2671653

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT plx-20180930.xml EX-101.INS 348264
8 XBRL TAXONOMY EXTENSION SCHEMA plx-20180930.xsd EX-101.SCH 24901
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20180930_cal.xml EX-101.CAL 30476
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20180930_def.xml EX-101.DEF 141568
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20180930_lab.xml EX-101.LAB 183765
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20180930_pre.xml EX-101.PRE 159289
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 181166776
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1